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In Brief
Bariatric surgery durably alters the
human gut microbiome. Here, Tremaroli
et al. demonstrate that two types of
bariatric surgery, Roux-en-Y gastric
bypass and vertical banded gastroplasty,
produce long-term alterations of the gut
microbiome independently of BMI and
that these alterations modulate host
metabolism and fat mass deposition.
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Bariatric surgery is currently the most effective pro-
cedure for the treatment of obesity. Given the role
of the gut microbiota in regulating host metabolism
and adiposity, we investigated the long-term effects
of bariatric surgery on the microbiome of patients
randomized to Roux-en-Y gastric bypass or vertical
banded gastroplasty and matched for weight and
fat mass loss. The two surgical procedures induced
similar and durable changes on the gut microbiome
that were not dependent on body mass index and re-
sulted in altered levels of fecal and circulatingmetab-
olites compared with obese controls. By colonizing
germ-free mice with stools from the patients, we
demonstrated that the surgically altered microbiota
promoted reduced fat deposition in recipient mice.
These mice also had a lower respiratory quotient,
indicating decreased utilization of carbohydrates as
fuel. Our results suggest that the gut microbiota
may play a direct role in the reduction of adiposity
observed after bariatric surgery.
INTRODUCTION
The prevalence of obesity and its metabolic comorbidities, such
as type 2 diabetes and cardiovascular disease, is on the rise
worldwide. Although a number of genetic and environmental fac-
tors have been identified, the mechanisms responsible for
excessive fat mass accumulation and development of obesity
are not fully understood. Recent research shows that our intes-
tinal microbes contribute to the regulation of energy homeosta-228 Cell Metabolism 22, 228–238, August 4, 2015 ª2015 The Authorsis and fat storage and may play a role in obesity and its compli-
cations (Karlsson et al., 2013; Qin et al., 2012; Smith et al., 2013;
Tremaroli and Ba¨ckhed, 2012). Indeed, obesity has been associ-
ated with altered gut microbiota composition, reduced microbial
diversity, and reduced gene richness (Le Chatelier et al., 2013;
Ley et al., 2005; Turnbaugh et al., 2009). In addition, dietary
weight loss interventions have been shown to increase gene
richness of the microbiota and shift its composition toward that
of lean individuals (Cotillard et al., 2013; Ley et al., 2006).
Bariatric surgery is currently the best treatment for sustained
weight loss and reduction of obesity-related comorbidities (Sjo¨s-
tro¨m et al., 2007, 2012). There are a number of bariatric surgery
procedures, of which Roux-en-Y gastric bypass (RYGB) is
considered one of the most effective, promoting both weight
reduction and improvement of metabolism (Sjo¨stro¨m et al.,
2007; Werling et al., 2013a). The underlying mechanisms have
not been fully elucidated, but reduced food ingestion, changes
in food preferences, increased satiety, release of satiety-pro-
moting gut hormones (e.g., glucagon-like peptide 1 [GLP-1]
and peptide YY [PYY]), increased gastric emptying, and a shift
in bile acid metabolism together with an increased signaling
through the bile acid nuclear receptor farnesoid X receptor
(FXR) have all been suggested to play a role (le Roux and Bloom,
2005; Miras and le Roux, 2013; Ryan et al., 2014).
Recent work has also indicated that the gut microbiota may
mediate some of the beneficial effects of bariatric surgery, and
changes in the composition and diversity of the gut microbiota
have been observed in the short term after RYGB in humans
(Furet et al., 2010; Graessler et al., 2013; Kong et al., 2013; Zhang
et al., 2009), as well as after vertical sleeve gastrectomy and
RYGB in mice (Liou et al., 2013; Ryan et al., 2014). However,
there are no long-term investigations of the stability of these
changes or of the effects of different procedures on the human
gut microbiota. Additionally, the causal link between the alter-
ations to the microbiota and the reduction in adiposity observeds
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Figure 1. Long-term Effects of Bariatric Surgery on Gut Microbiota Composition
(A) Scatter plot of median species abundance in RYGB patients and severely obese subjects (OBS).
(B) Scatter plot of median species abundance in VBG patients and OBS subjects.
(C) Scatter plot of median species abundance in RYGB and VBG patients.
The genus affiliations of differentially abundant species are indicated by color (Adj. p < 0.05, Wilcoxon rank-sum test). See also Table S3.after bariatric surgery has not been previously analyzed in
humans.
Here we used shotgun sequencing of the human fecal meta-
genome to analyze the gut microbiota of weight-stable women
9 years after randomization to either RYGB or vertical banded
gastroplasty (VBG) (Olbers et al., 2006) and matched for weight
and fat mass loss. As a reference, we also analyzed the gut mi-
crobiota of two groups of non-operated women with body mass
index (BMI) matched to the patients’ pre-surgical BMI (OBS) and
post-surgical BMI (Ob). We aimed to identify whether alterations
in the gut microbiota observed previously in the short term re-
mained stable over time and if RYGB and VBG induced specific
alterations in the gut microbiome. Moreover, we investigated the
causal link between the surgically altered human gut microbiota
and adiposity phenotype by performing microbiota transplanta-
tions of human stools in germ-free (GF) mice.
RESULTS AND DISCUSSION
Bariatric Surgery has Long-Term Effects on Gut
Microbiota Composition
To investigate the long-term effects of bariatric surgery on the
gut microbiota, we obtained fecal samples from 14 women 9.4
years after they were randomized to RYGB (n = 7) or VBGCel(n = 7) (Olbers et al., 2006). These women were included in a
recent study of the mechanisms underlying the maintenance of
long-term weight loss (Werling et al., 2013b). RYGB and VBG
patients were matched for pre- and post-operative weight,
BMI, and body composition, and had thus experienced similar
weight and fat mass loss. We also included fecal samples from
seven non-operated women with severe obesity (OBS) and a
BMI similar to the mean pre-surgical BMI of RYGB and VBG
patients. Clinical and biometric measurements of these three
groups of women are summarized in Table S1.
Genomic DNA was extracted from fecal samples using a
repeated bead beating procedure (Salonen et al., 2010) and
sequenced on Illumina HiSeq 2000. In total, we obtained 63
Gbp of paired-end reads, with an average of 3.0 ± 3.0 (SD)
Gbp for each sample (Table S2). To determine the composition
of the gut microbiota, we aligned high-quality Illumina reads
devoid of human DNA to 2,382 reference genomes obtained
from the National Center for Biological Information (NCBI) and
the Human Microbiome Project (HMP) databases (http://
hmpdacc.org) (Table S2) using methods from our MEDUSA plat-
form (Karlsson et al., 2012; Karlsson et al., 2014).
We observed significant differences inmicrobiota composition
for RYGB versus OBS samples, but not for VBG versus OBS or
RYGB versus VBG (Figure 1; Table S3). The abundance ofl Metabolism 22, 228–238, August 4, 2015 ª2015 The Authors 229
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Figure 2. Functional Differences in the Mi-
crobiomes of RYGB, VBG and OBS Subjects
as Measured by the Abundance of KOs
(A) Comparison of RYGB versus OBS samples.
(B) Comparison of VBG versus OBS samples.
(C) Comparison of RYGB versus VBG samples.
Each spot represents a KO, and red spots repre-
sent KOs whose abundance is significantly
different. FC, fold change; CPM, counts per
million. See also Table S4 and Figures S1 and S2.species belonging to 29 microbial genera differed significantly
betweenRYGBandOBSsamples (Figure 1A; TableS3); in partic-
ular, the levels of several species in the Gammaproteobacteria
class were higher while the levels of three species in the Firmi-
cutes phylum (Clostridium difficile, Clostridium hiranonis, and
Gemella sanguinis) were lower in RYGB versus OBS samples
(Table S3). At the genus level, several facultative anaerobes in
the Proteobacteria (e.g., Escherichia, Klebsiella, and Pseudo-
monas) were present at increased relative abundance in RYGB
(TableS3).Weobservedadifferent relativeabundance for several
species when comparing VBG with OBS samples, and RYGB
with VBG samples, although the differences were not significant
after correction formultiple testing (Table S3).E. coli tended to in-
crease, while Eubacterium rectale and Roseburia intestinalis
tended to decrease in VBG compared to OBS (Table S3). Klebsi-
ella species tended to increase, while Bifidobacterium species
tended to decrease in RYGB in comparison to VBG (Table S3).
These analyses demonstrated that women who have under-
gone RYGB had increased abundance of Proteobacteria in com-
parison to non-operated severely obese women. Proteobacteria
are generally not considered to be beneficial due to their proin-
flammatory properties (Amar et al., 2011; Cani et al., 2007; Mu-
khopadhya et al., 2012). However, the RYGB and VBG patients
in our study were not under inflammatory stress as determined
by plasma CRP levels (Table S1). Moreover, our results are in
agreement with previous findings showing an expansion of Pro-
teobacteria shortly after RYGB, both in humans (Furet et al.,
2010; Graessler et al., 2013; Kong et al., 2013; Zhang et al.,
2009) and mice (Liou et al., 2013). Additionally, despite the
obvious differences between the two surgical procedures (Olb-
ers et al., 2006), we did not observe distinct microbiota profiles
for RYGB and VBG patients. Although this result could be due
to the small sample size of our cohort, it is also possible that other230 Cell Metabolism 22, 228–238, August 4, 2015 ª2015 The Authorsmechanisms common to the two surgical
procedures might affect the composition
of the gut microbiota. For example, in-
creases in pH have been shown to pro-
mote the growth of E. coli in vitro (Duncan
et al., 2009), and both RYGB and VBG are
associated with reduced luminal expo-
sure to gastric acidity.
Bariatric Surgery Has Long-Term
Effects on the Genetic Content of
the Gut Microbiota
To explore the genetic content of the gut
microbiome after bariatric surgery, wealigned our reads to the MetaHIT human gut microbial gene cat-
alog (Qin et al., 2010). We calculated the abundance of KEGG or-
thologs (KOs), and analyzed the abundance of KEGG pathways
using the reporter features algorithm to obtain a global view of
the changes (Oliveira et al., 2008; Patil and Nielsen, 2005).
We observed differences in the microbiome of operated and
non-operated severely obese women (Figure 2; Table S4): 928
KOs were enriched and 60 were depleted in RYGB versus
OBS samples (Figure 2A; Table S4), while 682 KOs were en-
riched and 33 were depleted in VBG versus OBS samples (Fig-
ure 2B; Table S4). However, only 17 KOs were differentially
abundant between RYGB and VBG samples, all enriched in
VBG (Figure 2C; Table S4).
The reporter pathways for phosphotransferase systems and
fluorobenzoate degradation were enriched in RYGB versus
OBS microbiomes, and the reporter pathways for flagellar as-
sembly, sulfur relay system, glutathione metabolism, glyoxylate
and dicarboxylate metabolism, ABC transporters (in particular
for lysine/arginine/ornithine, histidine, and putrescine), and
phenylalanine metabolism were enriched in VBG versus OBS
samples (Table 1; Table S4). In addition, the reporter pathways
for nitrogenmetabolism, fatty acidmetabolism, and two-compo-
nent systems were enriched both in RYGB versus OBS and VBG
versus OBS microbiomes (Tables 1 and S4).
Two-component systems are sensory systems that enable
bacteria to sense and respond to changes in the surrounding
environment (Mascher et al., 2006). We found that the two-
component systems responding to nitrogen availability (nifA),
phosphoglycerate transport (pgtCAP), and short-chain fatty
acid (SCFA) metabolism (acetoacetate, atoCE) were specifically
enriched in RYGB compared to OBS, while salt stress response
and twitching motility were specifically enriched in VBG
compared to OBS (Table S4). Two-component system genes
Table 1. KEGG Pathways Enriched in the Gut Microbiomes of
RYGB and VBG Patients in Comparison to OBS Women
RYGB Enriched Compared
to OBS
VBG Enriched Compared
to OBS
– Flagellar assembly
– Sulfur relay system
– Glutathione metabolism
– Glyoxylate and dicarboxylate
metabolism
– ABC transporters
– Phenylalanine metabolism
Nitrogen metabolism Nitrogen metabolism
Fatty acid metabolism Fatty acid metabolism
Two-component system Two-component system
Phosphotransferase system –
Fluorobenzoate degradation –for response to antimicrobial peptides, outer membrane stress,
and trimethylamine N-oxide (TMAO) were enriched in both
RYGB and VBG compared to OBS microbiomes. Furthermore,
the gene coding for TMAO reductase (torA, K07811), which is
involved in the respiration of TMAO to TMA, was also enriched
in both RYGB and VBG compared to OBS microbiomes
(Table S4).
The increase in tor genes likely reflects the high levels of E. coli
in both RYGB and VBG samples, as E. coli can use TMAO as a
terminal electron acceptor (Barrett and Kwan, 1985). However,
we observed increased plasma concentrations of TMAO only
in RYGB and not in VBG women (Figure S1A); the levels of
choline and betaine, known dietary precursors for TMA produc-
tion by the gutmicrobiota, did not differ between the groups (Fig-
ures S1B and S1C). The increased levels of TMAO in RYGB
samples might be the consequence of a less anaerobic meta-
bolism in the RYGB intestine, which is supported by the broad
increase of facultative anaerobes in RYGB microbiomes, and
could occur due to the shortening of the small bowel. We spec-
ulate that TMAO could be produced in the intestine by oxidation
of TMA catalyzed by TMA monooxygenase; this enzyme is pre-
sent in bacteria such as Pseudomonas (Barrett and Kwan, 1985),
which showed increased abundance in RYGB microbiomes.
These observations are of interest because high TMAO levels
linked to TMAoxidation by the human hepatic flavinmonooxyge-
nase FMO3 have been associated with cardiovascular diseases
(CVDs) (Tang et al., 2013; Wang et al., 2011), while it is known
that RYGB is associated with a lower CVD risk (Sjo¨stro¨m et al.,
2012).
Bariatric Surgery Has Long-Term Effects on Microbial
Fermentation
The enrichment of KOs related to phosphoglycerate, acetoace-
tate, and SCFAs transporters and to phosphotransferase sys-
tems pointed to increased energy flux into sugar metabolism
and glycolysis in RYGB microbiomes. By contrast, the enrich-
ment of pathways for amino acid uptake and metabolism and
for glyoxylate metabolism pointed to the utilization of amino
acids and acetate for energy production by the VBG micro-
biome. As the fermentation activities of the gut microbiotaCelcontribute to host nutrition and health (Flint et al., 2012), we func-
tionally tested whether the differences in the microbiome re-
sulted in altered microbial fermentation of carbohydrate and
protein by measuring the levels of fecal SCFAs and branched-
chain fatty acids (BCFAs). The SCFAs acetate, propionate, and
butyrate were present in comparable proportions, but their con-
centrations tended to decrease in RYGB and VBG samples (Fig-
ures S2A–S2D), while the BCFAs isobutyrate and isovalerate,
produced from the amino acids valine and leucine, respectively,
either showed no change or a slight tendency to increase in
RYGB and VBG samples (Figures S2E–S2G). As a result, we
observed a decrease in the SCFA/BCFA ratio for bariatric sur-
gery samples, which was significant for RYGB (Figure S2H).
Importantly, total fiber intake did not differ, while protein intake
decreased for RYGB and VBG women (Table S1), indicating
that the lower SCFA/BCFA ratio was not a consequence of die-
tary consumption.
The similar SCFA/BCFA ratio and the analysis of pathways en-
riched in RYGB and VBG compared to OBS subjects reveal
some common effects of the two bariatric surgery procedures
and indicate altered intestinal fermentation shifted toward
reduced production of SCFAs and increased amino acid
fermentation after bariatric surgery. As the total fiber intake
was similar for RYGB, VBG, and OBS patients, our results point
to a diet-independent adaptation of the gut microbiota to bariat-
ric surgery. In particular the decreased SCFAs levels in RYGB
and VBG fecal samples also point to reduced energy harvest
from the diet, as previously proposed (Turnbaugh et al., 2006).
Bariatric Surgery Has Long-Term Effects on Bile Acid
Metabolism
Bile acids are cholesterol metabolites that facilitate the absorp-
tion of dietary fat and fat-soluble molecules and are now also
recognized as regulators of energy metabolism through activa-
tion of the receptors TGR5 and FXR (Hylemon et al., 2009; Lefeb-
vre et al., 2009). Increased circulating levels of primary and
secondary bile acids have been observed after RYGB (Ahmad
et al., 2013; Glicksman et al., 2010; Kohli et al., 2013; Patti
et al., 2009) and have been linked to increased GLP-1 and
reduced glucose and triglyceride levels (Nakatani et al., 2009;
Patti et al., 2009; Pournaras et al., 2012; Simonen et al., 2012).
The postprandial bile acid response is blunted in obesity and
enhanced after RYGB, indicating that this response might be
important for inducing satiety, reduced food intake, and lower
body weight (Ahmad et al., 2013; Glicksman et al., 2010).
Because the composition of the bile acid pool is regulated by
the gut microbiota (Sayin et al., 2013), we examined the relation-
ship between the altered gut microbiota and bile acid pool
composition after bariatric surgery. We quantified putative
microbial genes for bile acid metabolism and showed that
levels of bsh genes (for bile salt hydrolases) did not differ, while
baiB, baiCD, baiE, baiF, and baiG (genes for the 7a-dehydroxy-
lation of primary bile acids) increased in RYGB compared to
OBS, although not significantly (Figure S3A). Fasting bile acid
concentrations did not differ between RYGB, VBG, and OBS
patients, but we confirmed a blunted postprandial bile acid
response for OBS women and observed a slight increase in
postprandial bile acid levels for VBG patients (Figures 3A and
3B), which was significant only for the secondary bile acidl Metabolism 22, 228–238, August 4, 2015 ª2015 The Authors 231
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Figure 3. Postprandial Bile Acid and FGF19 Responses in RYGB, VBG, and OBS Women
(A) Circulating concentrations of total bile acids (Total BA), total conjugated primary (G+T primary), total conjugated secondary (G+T secondary), glycine-
conjugated primary (G-primary), glycine-conjugated secondary (G-secondary), taurine-conjugated primary (T-primary), taurine-conjugated secondary
(T-secondary), unconjugated primary, and unconjugated secondary bile acids.
(legend continued on next page)
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glycine-conjugated lithocholic acid (Figure S3B). However, we
observed a pronounced postprandial bile acid response in
RYGB compared to OBS patients, with a significant increase in
total and glycine- and taurine-conjugated bile acids, but not un-
conjugated bile acids (Figures 3A and 3B). The increased bile
acid levels in RYGB women were attributable to increases in
both primary and secondary conjugated bile acids (Figure S3B,
ANOVA p < 0.05). Finally, we measured the circulating levels of
FGF19, an intestinal factor that regulates bile acid, carbohydrate,
lipid, and energy metabolism through bile acid-mediated activa-
tion of FXR (Beenken and Mohammadi, 2009). We observed an
increased FGF19 response in RYGB women compared to OBS
(Figure 3C), indicating increased FXR signaling.
Our results provide evidence for an increased abundance in
RYGBmicrobiomes of microbial genes involved in the dehydrox-
ylation of primary to secondary bile acids, which is in line with the
increased response of secondary bile acids in RYGB patients.
However, these results need to be further validated in larger
cohorts and at shorter time points after bariatric surgery.
Analysis of BMI as a Possible Confounding Factor
To control for differences in BMI, we compared the gut micro-
biome of RYGB and VBG patients with that of non-operated
women (Ob, n = 9) with BMI matched to the post-surgical BMI
of the RYGB and VBG patients (BMI = 31.9 ± 2.7 [SD]) (Table
S1 and S5). The Ob group was selected from a larger cohort
recently analyzed with methods comparable to those used
here (Karlsson et al., 2013). We found again an expansion in Pro-
teobacteria and a reduction in several clostridial species after
RYGB, and also a significant increase in the relative abundance
of three E. coli species in VBG (Figure 4A; Table S5).
We observed differences in the genetic content of RYGB,
VBG, and Ob microbiomes (Figure 4B; Table S5). Several path-
ways (e.g., two-component systems, fluorobenzoate degrada-
tion, and glyoxylate and dicarboxylate metabolism) and KOs
(e.g., nifA, pgtCAP, ato, and deg genes) enriched in RYGB or
VBG compared to OBS were also enriched in comparison to
Ob microbiomes (Table S5). In particular, torA (K07811) was en-
riched in RYGB and VBG compared to both OBS and Ob
(Figure S4).
These results indicate that the differences in gut microbiota
composition and genetic content result from bariatric surgery
and not BMI per se, since the OBS and Ob microbiomes were
similar (Figure 4; Table S5). Indeed, previous studies of the gut
microbiota during dietary interventions for weight loss have not
reported an increase in Proteobacteria but a shift in taxa such
as Bacteroidetes (Ley et al., 2006), Eubacterium/Roseburia
(Duncan et al., 2008), and Eubacterium rectale (Cotillard et al.,
2013). Together with these observations, our results suggest
that bariatric surgery produces a specific shift in the microbiota
that persists for up to a decade after surgery and is different from
shifts related to dietary interventions for weight loss.(B) Tukey box plots showing the area under the curve (AUC) as a measure of the
(C) Circulating concentrations of FGF19 and AUC showing FGF19 postprandial r
Plasma samples were collected during fasting and every 30 min for 2.5 hr after a s
one in the VBG group) were excluded from the analysis, and plasma from one VBG
RYGB, five VBG, and seven OBSwomen. a p < 0.05 according to one-way ANOVA
See also Figure S3.
CelTransmission of the Human Adiposity Phenotype by
Transplantation of the Gut Microbiota
To investigate whether the altered gutmicrobiota of bariatric sur-
gery patients directly affects adiposity and metabolism, we
transplanted the fecal microbiota of RYGB, VBG, and OBS
patients into female GF mice. We observed that mice colonized
with RYGB and VBG microbiota for 2 weeks accumulated 43%
and 26% less body fat, respectively, than mice colonized with
OBSmicrobiota (Figure 5A), while mice colonized with RYGBmi-
crobiota had the highest average increase in lean mass (Figures
S5A–S5C); body weight gain and food intake did not differ be-
tween the groups during the 2-week colonization period (Figures
S5D and S5E). In addition, we measured oxygen (O2) consump-
tion and carbon dioxide (CO2) production in the mice colonized
with RYGB, VGB, and OBS microbiota. Although O2 consump-
tion, body weight gain, and food intake did not differ during the
measurements (Figures S5F–S5I), GF mice colonized with
RYGB microbiota had a lower respiratory quotient ([RQ]; ratio
between CO2 produced and O2 consumed) than mice colonized
with OBS microbiota (active phase, Night1, Figure 5B) or with
VBG microbiota (resting phase, Figure 5C), thus indicating
decreased utilization of carbohydrates and increased utilization
of lipids as fuel in recipients of RYGB microbiota.
The reduced fat mass gain in GFmice transplanted with RYGB
and VBG microbiota is in agreement with our results on the
composition of the gut microbiome and with a short-term human
study showing an inverse correlation between E. coli abundance
and fat mass after RYGB (Furet et al., 2010). These results are
also consistent with a mouse study showing a reduced ability
of the RYGB microbiota to promote adiposity (Liou et al.,
2013). As we observed decreased SCFAs in RYGB and VBG
samples, reduced energy harvest from the diet might be amech-
anism for the reduced fat mass gain in themice transplanted with
bariatric surgery microbiota.
We also observed that mice receiving RYGB microbiota
gained the least fat mass and had a reduced RQ, suggesting
reduced utilization of carbohydrates and increased utilization
of fat for metabolic processes. Reduced RQ has been observed
in humans after RYGB and associated to reduced glucose oxida-
tion, increased lipid oxidation, and increased plasma levels of
conjugated bile acids (Simonen et al., 2012). As we found
increased levels of secondary bile acids in the plasma of
RYGB patients, microbial regulation of bile acid metabolism
could contribute to the improved metabolic phenotype of
RYGB patients by promoting increased utilization of fat, and to
the superior long-term weight loss and metabolic improvements
observed after RYGB compared to VBG (Sjo¨stro¨m et al., 2007;
Werling et al., 2013a). However, as we compared the micro-
biomes of RYGB and VBG patients matched for weight loss,
future studies of the microbiome from patients achieving
different levels of weight and fat loss are required to validate
our findings.bile acid postprandial responses.
esponse in RYGB, VBG, and OBS women.
tandard meal. Samples from colecystectomized patients (one in the RYGB and
woman could not be obtained, so the results represent the mean ± SEM for six
with Tukey’s correction for multiple comparisons for RYGB compared to OBS.
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Figure 4. Gut Microbiome of RYGB and VBG Women in Comparison to Non-Operated Women (Ob) with BMI Matched to the Post-Surgical
BMI of the Bariatric Surgery Patients
(A) Gut microbiota composition. Scatter plot of median species abundance in RYGB andOb, in VBG and Ob, and in Ob andOBSwomen. The genus affiliations of
differentially abundant species are indicated by color (Adj. p < 0.05, Wilcoxon rank-sum test).
(B) Functional differences in themicrobiomes measured by the abundance of KOs. Each spot represents a KO, and red spots represent KOswhose abundance is
significantly different. The number of KOs significantly increased (up) and depleted (down) is shown under each plot. The direction of change is defined as up
being the title above and down being the title to the right of each plot. FC, fold change; CPM, counts per million. See also Table S5 and Figure S4.PERSPECTIVE
Our study shows that bariatric surgery has long-term effects on
the composition and functional capacity of the gut microbiota
and that these changes have the potential to modulate host
metabolic regulation, thus adding evidence for the transmissi-
bility of the human adiposity phenotype through the gut
microbiota.234 Cell Metabolism 22, 228–238, August 4, 2015 ª2015 The AuthorOur results also show that two different bariatric surgery pro-
cedures, namely RYGB and VBG, have similar long-term effects
on the gut microbiome in women matched for BMI and fat
mass loss. However, the two bariatric surgery procedures
might result in different functionality due to different intestinal
environmental conditions, as we exemplified for TMA/TMAO
metabolism. Importantly, the changes in the microbiome were
not dependent on BMI or degree of weight and fat mass loss,s
AB
C
Figure 5. The Gut Microbiota Influences Fat Accumulation and Metabolism in Colonized Mice
(A) Fat gain in mice colonized with human stools from OBS, RYGB, and VBG women. Fat gain was calculated as the difference between fat content normalized
over body weight at the end of the experiment (d14) and fat content normalized over body weight 1 day after colonization (d1). The results presented were
obtained from colonization of GFmicewith fecal microbiota from two patients in each of the RYGB, VBG, andOBSgroups (four to fivemice per donormicrobiota).
(B) RQ (ratio between CO2 produced and O2 consumed) calculated for the light and dark phases and for the overall 22 hr period in the Somedic chamber.
(C) RQ in the resting phase (basal RQ, calculated as the average RQ for the lowest 10 min average of O2 consumption).
The results presented in (B) and (C) were obtained from colonization of GF mice with fecal microbiota from three patients in each of the RYGB, VBG, and OBS
groups (3–5 mice per donor microbiota).
Bars show the results of colonization with the same donor microbiota, with black dots showing individual mice and lines indicating the mean. Statistical
significance of differences between themeanswas tested by one-way ANOVAwith Tukey’s correction formultiple comparisons (a p < 0.05 for RYGB compared to
OBS, b p < 0.05 for VBG compared to OBS, and c p < 0.05 for RYGB compared to VBG). See also Figure S5.thus revealing shifts in the gut microbiota that were specific to
bariatric surgery.
EXPERIMENTAL PROCEDURES
Subjects and Sample Collection
The operated women included in this study participated in a previous clinical
trial for the measurement of energy expenditure after RYGB (n = 7) andCelVBG (n = 7) (Werling et al., 2013b). The clinical trial and the enrollment of
subjects were described previously (Werling et al., 2013b). We also included
samples from severely obese women with a BMI similar to the mean pre-
surgical BMI of the operatedwomen (OBS, n = 7), and thesewomen underwent
measurements of energy expenditure as the RYGB and VBG patients. None
of the women included in our study had diabetes. However, the RYGB patients
had significantly reduced fasting insulin compared with OBS, whereas there
was a trend toward reduction in the VBG patients (Table S1).l Metabolism 22, 228–238, August 4, 2015 ª2015 The Authors 235
Blood samples were collected during the measurements of energy expen-
diture in the indirect calorimetry chamber; 17 out of 21 stool samples were
also collected during the measurements, while the remaining four samples
were collected at home 2 to 8 days after. Stool samples collected in the
calorimetry chamber were immediately frozen at 80C. Samples collected
at home were kept at room temperature and mailed to the hospital, where
they arrived within 24 hr from collection and were immediately frozen
at 80C. The 21 women in our study did no use antibiotics for at least
6 weeks before inclusion in the study. The studies were performed in
accordance with the Declaration of Helsinki and were approved by the
Regional Ethical Review Board in Gothenburg, Sweden (no: 359-09 and
740-10). All study participants were informed verbally and in writing and
signed a consent form.
Quantification of Organic Acids, TMAO, and Bile Acids
Fecal SCFAs and BCFAs were determined by gas chromatography-mass
spectrometry (GC-MS) as previously described (Ryan et al., 2014). TMAO,
choline, betaine, and bile acids were extracted from plasma samples and
measured by ultra-performance liquid chromatography-tandem mass spec-
trometry (UPLC-MS/MS). Detailed methods are provided in the Supplemental
Experimental Procedures.
DNA Extraction and Metagenome Data Analysis
Genomic DNA was extracted from fecal samples using repeated bead beating
(Salonen et al., 2010). DNA fragments of approximately 300 bp were
sequenced on an Illumina HiSeq 2000 instrument. Metagenomic sequence
data was analyzed using methods from the MEDUSA platform (Karlsson
et al., 2012, 2014). The statistical analysis was performed in the software R
(R Core Team, 2012). All p values were corrected for multiple testing with
the method from Benjamini and Hochberg (1995). Detailed methods are pro-
vided in the Supplemental Experimental Procedures.
Mouse Experiments
For microbiota transplantations, we selected stool samples from three
RYGB, three VBG, and three OBS patients who did not use medications
and did not receive cholecystectomy and used these samples to colonize
GF Swiss Webster female mice in three independent experiments. Mice
were colonized by oral gavage of fecal slurry at 8–10 weeks of age, for a
period of 2 weeks; more details are provided in the Supplemental Experi-
mental Procedures. Mice were fed autoclaved chow and sterile water;
food consumption and body weight were recorded 1, 7, and 14 days after
colonization. In two of the experiments, body composition was determined
with an EchoMRI instrument (EchoMRI) 1 and 14 days after colonization.
All mice were analyzed by indirect calorimetry in the Somedic INCA system
(Somedic, Ho¨rby) for measurements of O2 consumption and CO2 production.
All animal experiments were approved by the Gothenburg Animal Ethics
Committee.
ACCESSION NUMBERS
Metagenomic sequence data has been deposited at the European Nucleotide
Archive under the accession number ENA: ERP009310.
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Supplemental Information includes five figures, five tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
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